Meeder Asset Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,763
Closed -$165K 2489
2020
Q2
$165K Buy
2,763
+2,216
+405% +$137K 0.01% 643
2020
Q1
$33K Sell
547
-2,280
-81% -$133K ﹤0.01% 1062
2019
Q4
$154K Sell
2,827
-842
-23% -$31.4K 0.01% 673
2019
Q3
$103K Buy
3,669
+37
+1% +$1.36K 0.01% 789
2019
Q2
$121K Buy
+3,632
New +$113K 0.01% 707

Other funds holding PRNB

Meeder Asset Management's PRNB Position: Q3 2020 in Review

Meeder Asset Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 2,763 shares — an estimated $165K sold.

Meeder Asset Management first reported a position in PRNB in Q2 2019 and held it in 5 quarters. The position peaked at $165K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Meeder Asset Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Meeder Asset Management sold 2,763 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $165K.
  • Meeder Asset Management first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • Meeder Asset Management's Principia Biopharma Inc. Common Stock position peaked at $165K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.